Related Experiment Videos
[Erythermalgia].
1Service des maladies cardio-vasculaires, Hôpital Cochin, Paris.
Journal Des Maladies Vasculaires
|January 1, 1988
Summary
Erythromelalgia, a rare vascular condition, primarily affects the feet and is triggered by heat. Treatments like aspirin and beta-blockers show promise by targeting platelet activity and potential nerve anomalies.
Area of Science:
- Vascular Medicine
- Dermatology
- Hematology
Context:
- Erythromelalgia is a rare vascular acrosyndrome primarily affecting the feet.
- Symptoms are often triggered by elevated room temperatures.
- It can be primary or secondary to conditions like polycythemia.
Purpose:
- To explore the underlying mechanisms of erythromelalgia.
- To understand the role of platelet count and prostaglandin cyclo-oxygenase in the condition.
- To investigate the potential involvement of cutaneous adrenergic nerves.
Summary:
- Erythromelalgia's pathophysiology involves vascular and potentially neurological factors.
- Increased platelet count in secondary erythromelalgia highlights the role of platelet aggregation.
- Aspirin and NSAIDs are effective due to their inhibition of platelet prostaglandin cyclo-oxygenase.
- Beta-blockers may offer benefits by addressing potential cutaneous adrenergic nerve anomalies.
Impact:
- Provides insights into the therapeutic mechanisms of aspirin, NSAIDs, and beta-blockers for erythromelalgia.
- Highlights the importance of considering platelet count and vascular anomalies in diagnosis and treatment.
- Contributes to a better understanding of this rare vascular acrosyndrome, guiding future research and clinical management.